Abstract
We report the synthesis and in vitro evaluation of novel beta-sheet breaker peptides as promising Aβ fibrillogenesis inhibitors. Further 3D-GRID pharmacophore and metadynamics simulations rationalized the design of these peptides.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have